Medial EalrySign develops AI-based clinical decision-support and population health solutions. We focus on the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases by applying machine learning algorithms on basic medical information, such as blood test results, medications and other EMR data. Our goal is to make these insights accessible by all stakeholders including healthcare organizations, doctors, and eventually patients

Visit website

Buttontwitter

Partners & Attendees

Acc1.001
Mit tech review.001
Nvidia.001
Svb.001
Facebook.001
Forbes.001
Applause .001
Twentybn.001
Sama21.001
Intel21.001
Rasalogo.001
Graphcoreai.001
This website uses cookies to ensure you get the best experience. Learn more